Intuit Inc. (NASDAQ:INTU) shares were trading higher by 0.56 percent ($0.86) at $154.77 a piece in Monday’s session. It had closed the previous session at $153.91. INTU trades with a P/S ratio of 7.38. This compares with the industry’s 5.58 and the wider sector’s 2.74. A low price-to-sales ratio, typically less than 1.0, is considered a good value. Also, it has an estimated price-earnings (P/E) multiple of 27.77 and a trailing 12-month price-earnings (P/E) multiple of 40.91. Shares of INTU have uptrended 12.23% in the past three months, while the S&P 500 has moved 5.19% in that time. Intuit Inc. (INTU) has a market cap of $38.98 billion and over the last 12 months, Intuit Inc. (NASDAQ:INTU) has gone stronger by 33.34%. During the last 52 weeks, the (NASDAQ:INTU) price has been as high as $158.9 and as low as $111.48. Intuit Inc. earnings have risen with an annualized rate of 8.2% over the last 5 years. The average 1-year price target for Intuit Inc. (INTU) — averaging the work of different analysts — reveals a mean PT of $155.72/share. That’s a potential 0.61 increase relative to where Intuit Inc. (NASDAQ:INTU) has been trading recently. The current price is seen ranging between $153.35 and $155.12. There are brokerage firms with lower targets than the average, including one setting a price target of $120. And then on the other side of the spectrum one analyst entrenched in the bullish camp has a target as high as $185. The collective rating of 2.4 for Intuit Inc. (NASDAQ:INTU) also leans strongly towards the neutral end of the spectrum. Of the 22 analysts surveyed by Reuters that track INTU 11 of them rate its stock a hold. The other 11, though not evenly; between analysts who think you should buy Intuit Inc. versus those who think you should sell it. A 9 analysts rate it as either a buy or a strong buy, while2 believe that investors should either steer clear of INTU or, if they already own its stock, sell it. Envision Healthcare Corporation (EVHC) pulled off a 0.57 percent gain and now trades for $30.07. EVHC comes in with a P/S ratio of 0.51 that’s below 1, potentially implying that it could be cheap relative to the overall sector (5.36) and its peers (12.62). Also, it has an estimated price-earnings (P/E) multiple of 9.81 . During the last 52 weeks, the price has been as high as $74.75 and as low as $23.77. Envision Healthcare Corporation (NYSE:EVHC) earnings have risen with a quarterly rate of 36.8% over the last 5 years. Shares of EVHC have sank -41.65% in the past three monthswhile the S&P 500 has dropped -46.07% in that time. Envision Healthcare Corporation (NYSE:EVHC) has a market cap of $3.66 billion and over the last 12 months, EVHC has declined by -54.59%. The average 1-year price target for (EVHC) reveals an average price target of $38.64 per share. That’s a potential 28.5 gain from where (NYSE:EVHC) has been trading recently. There are brokerage firms with lower targets than the average, including one setting a price target of $30. And then on the other side of the spectrum one analyst entrenched in the bullish camp has a target as high as $71. The consensus recommendation — averaging the work of 15 analysts — of 1.6 for Envision Healthcare Corporation (EVHC) points to bullish case. Of the analysts surveyed by Reuters that track Envision Healthcare Corporation 5 of them rate its stock a hold. The other 10 are split, though not evenly, between analysts who think you should buy its stock versus those who think you should sell it. A 10 analysts rate it as either a buy or a strong buy, while 0 believe that investors should either steer clear of (NYSE:EVHC) or, if they already own its stock, sell it.




(adsbygoogle = window.adsbygoogle || []).push({});
